The following investigators received rhBMP-2 data while the data were being made available between June 2013 and June 2015. Links to their protocols and publications are included.
|Date Data Request Approved||Principal Investigator||Institution||Name of Project||Protocol||Publications|
|October 10, 2013||Amber Laurie, MS and Rochelle Fu, PhD||Oregon Health and Science University||Meta-analysis of the influence of patient characteristics on the effectiveness and harms of recombinant human bone morphogenetic protein-2 (rhBMP-2) in lumbar spinal fusion||Published in Spine September 15, 2016. Article available here.|
|October 21, 2013||Alex Hodkinson, MSc||University of Liverpool||Differences in the reporting of harms data in internal sponsored reports versus the corresponding published trial reports: Evaluating the safety reporting of rhBMP-2 in 17 Medtronic sponsored trials||Data Transferred, Project Not Pursued, Certificate of Data Destruction Received|
|November 14, 2013||Andrew Indresano, MD||University of Wisconsin-Madison||A Re-evaluation of Carcinogenicity and rhBMP-2: A Meta-Analysis of the Individual Participant-Level Data from the Yale University Open Data Access (YODA) Project||Data Transferred, Project Not Pursued, Certificate of Data Destruction Received|
|January 16, 2014||Vikas Patel, MD||University of Colorado||Meta-analysis of the Outcomes and Complications in the Spinal Surgery Population Receiving Recombinant Human Bone Morphogenetic Protein-2 vs. Those Receiving Iliac Crest Bone Graft||Published in Spine August 13, 2015. Article available here.|